AJTMH ASTMH MEMBERSHIP INFORMATION: astmh@astmh.org
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am. J. Trop. Med. Hyg., 30(1), 1981, pp. 184-189
Copyright © 1981 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koff, W. C.
Right arrow Articles by Halstead, S. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koff, W. C.
Right arrow Articles by Halstead, S. B.

Suppression of Dengue Virus Replication in Vitro by Rimantadine Hydrochloride*

Wayne C. Koff, Joe L. Elm, Jr. AND Scott B. Halstead
Department of Tropical Medicine and Medical Microbiology, John A. Burns School of Medicine, University of Hawaii, 3675 Kilauea Avenue, Honolulu, Hawaii 96816

The effects of rimantadine on dengue virus replication were examined in a variety of tissue culture systems. The growth of dengue virus type 2 in human peripheral blood leukocytes (PBL) was completely suppressed when rimantadine was included in the culture medium at a concentration of 25 µg/ml. Similarly, rimantadine caused a significant inhibition of dengue virus replication in cultures of rhesus monkey PBL. Addition of drug into virus-infected LLC-MK2 cell cultures caused a decrease in the production of all four types of dengue virus. Maximal inhibition of dengue virus replication by rimantadine was observed when the drug was added immediately following the viral adsorption period. Rimantadine did not induce any cytopathic effects on either LLC-MK2 cells or PBL at concentrations less than 75 µg/ml. These findings demonstrate that rimantadine is an effective inhibitor of dengue virus replication in vitro, and indicate a need for further examination of the efficacy of rimantadine against severe dengue virus disease.

Accepted for publication May 10, 1980.


* The excellent technical assistance of Susan Kihara was sincerely appreciated. This work was supported by USPHS NIH Grant No. 2 R01 HD08963.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1981 by the American Society of Tropical Medicine and Hygiene.